D-0105-2027 Class II Ongoing
FDA drug recall D-0105-2027 was initiated by Eagle Pharma Outsourcing LLC on Oct 8, 2026 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is ongoing. Affected quantity: 50 250 mL-containers.
Recall details
- Product Type
- Drugs
- Report Date
- Nov 4, 2026
- Initiation Date
- Oct 8, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 50 250 mL-containers
Product description
PHENYLephrine HCL Infusion, 100 mg per 250 mL in 0.9% Sodium Chloride (0.4 mg/mL), Sterile, Rx Only, Single-Use Container, EAGLE PHARMA OUTSOURCING, 2200 Riverchase Center, Suite 675, Hoover, AL 35244, UPC: 6985210025. NDC 69852-100-25
Reason for recall
Lack of Assurance of Sterility
Distribution pattern
Nationwide within the U.S
Code information
Lot: PHENYL100-1004, Expiry: 12/31/2026.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0105-2027
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026